Sirolimus-Eluting Coronary Stent - Vietnam Registration 2402032ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Sirolimus-Eluting Coronary Stent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402032ĐKLH/BYT-HTTB and manufactured by Kamal Encon Industries Limited. The authorized representative in Vietnam is CÔNG TY TNHH ANDAMAN MEDICAL VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Theo theo phụ lục, Theo phụ lục, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402032ĐKLH/BYT-HTTB
18006199/ĐKLH-BYT-TB-CT
Theo theo phụ lục
Theo phụ lục
Technical Details
The Sirolimus-coated stent is designed for use in patients who are candidates for percutaneous transluminal coronary angioplasty (PTCA). The product is indicated to improve the coronary artery lumen in patients with symptomatic ischemic heart disease due to de novo, fragmented lesions, with a length ≤ 47 mm, in the native coronary arteries with a reference vessel diameter ranging from 2.00 to 4.50 mm.
Dates and Status
Aug 27, 2024
Sirolimus-Eluting Coronary Stent Frame
Theo phụ lục
2403645ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent Frame
Theo phụ lục
2402764ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent Frame
Theo theo phụ lục
2301854ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent Frame
Theo theo phụ lục
2301557ĐKLH/BYT-HTTB
Sirolimus-Eluting Coronary Stent
Theo theo phụ lục
2301208ĐKLH/BYT-HTTB